Shopping Cart 0
Cart Subtotal
AED 0

Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Advaxis Inc (ADXS)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T cells directed against a cancer antigen, and lessen factors that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Under the Lm Technology platform, the company has four immunotherapy candidates in development, Axalimogene filolisbac (AXAL) in Human Papilloma Virus (HPV)-associated cancers; Neoantigen Therapy (ADXS-NEO); ADXS-PSA in prostate cancer; and ADXS-HER2 in HER2-expressing solid tumors. Advaxis is headquartered in Princeton, New Jersey, the US.

Advaxis Inc Key Recent Developments

Feb 06,2019: Advaxis presents an overview of its Lm platform and neoantigen-directed programs at the Immuno-Oncology 360 Conference

Jan 28,2019: Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference

Jan 10,2019: Advaxis reports fiscal year 2018 financial results and provides a business update

Nov 06,2018: Advaxis to Present Poster Entitled Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy at Society for Immunotherapy of Cancer Annual Meeting

Nov 02,2018: Advaxis Provides Update on Clinical Pipeline

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Advaxis Inc-Key Facts

Advaxis Inc-Key Employees

Advaxis Inc-Key Employee Biographies

Advaxis Inc-Major Products and Services

Advaxis Inc-History

Advaxis Inc-Company Statement

Advaxis Inc-Locations And Subsidiaries

Head Office

Section 2-Company Analysis

Company Overview

Advaxis Inc-Business Description

Advaxis Inc-Corporate Strategy

Advaxis Inc-SWOT Analysis

SWOT Analysis-Overview

Advaxis Inc-Strengths

Advaxis Inc-Weaknesses

Advaxis Inc-Opportunities

Advaxis Inc-Threats

Advaxis Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Advaxis Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 06, 2019: Advaxis presents an overview of its Lm platform and neoantigen-directed programs at the Immuno-Oncology 360 Conference

Jan 28, 2019: Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360 Conference

Jan 10, 2019: Advaxis reports fiscal year 2018 financial results and provides a business update

Sep 10, 2018: Advaxis reports fiscal 2018 third quarter financial results

Jul 10, 2018: Advaxis Provides Update on MAA Filing and ADXS-HOT Program

Jun 07, 2018: Advaxis Announces Prioritization of Product Portfolio and Reports Fiscal 2018 Second Quarter Financial Results

Jun 06, 2018: Advaxis Appoints Molly Henderson as Chief Financial Officer

May 22, 2018: COMECER AMERICA signs a new agreement for the production of an aseptic manufacturing system (isolator technology) for Advaxis

Apr 23, 2018: Advaxis Announces Executive Leadership Changes

Mar 12, 2018: Advaxis Announces Q1 Fiscal 2018 Financial Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Advaxis Inc, Performance Chart (2014-2018)

Advaxis Inc, Ratio Charts

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Advaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Advaxis Inc, Key Facts

Advaxis Inc, Key Employees

Advaxis Inc, Key Employee Biographies

Advaxis Inc, Major Products and Services

Advaxis Inc, History

Advaxis Inc, Key Competitors

Advaxis Inc, Ratios based on current share price

Advaxis Inc, Annual Ratios

Advaxis Inc, Annual Ratios (Cont...1)

Advaxis Inc, Interim Ratios

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Advaxis Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Advaxis Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Oncolytics Biotech Inc

Neon Therapeutics Inc

MedImmune LLC

ISA Pharmaceuticals BV

Inovio Pharmaceuticals Inc

Celldex Therapeutics Inc

Cascadian Therapeutics Inc

Agenus Inc

Advantagene Inc

Aduro BioTech Inc

Company Profile

Company Profile Title

Advaxis Inc (ADXS)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T cells directed against a cancer antigen, and lessen factors that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Under the Lm Technology platform, the company has four immunotherapy candidates in development, Axalimogene filolisbac (AXAL) in Human Papilloma Virus (HPV)-associated cancers; Neoantigen Therapy (ADXS-NEO); ADXS-PSA in prostate cancer; and ADXS-HER2 in HER2-expressing solid tumors. Advaxis is headquartered in Princeton, New Jersey, the US.

Advaxis Inc Key Recent Developments

Feb 06,2019: Advaxis presents an overview of its Lm platform and neoantigen-directed programs at the Immuno-Oncology 360 Conference

Jan 28,2019: Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference

Jan 10,2019: Advaxis reports fiscal year 2018 financial results and provides a business update

Nov 06,2018: Advaxis to Present Poster Entitled Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy at Society for Immunotherapy of Cancer Annual Meeting

Nov 02,2018: Advaxis Provides Update on Clinical Pipeline

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Advaxis Inc-Key Facts

Advaxis Inc-Key Employees

Advaxis Inc-Key Employee Biographies

Advaxis Inc-Major Products and Services

Advaxis Inc-History

Advaxis Inc-Company Statement

Advaxis Inc-Locations And Subsidiaries

Head Office

Section 2-Company Analysis

Company Overview

Advaxis Inc-Business Description

Advaxis Inc-Corporate Strategy

Advaxis Inc-SWOT Analysis

SWOT Analysis-Overview

Advaxis Inc-Strengths

Advaxis Inc-Weaknesses

Advaxis Inc-Opportunities

Advaxis Inc-Threats

Advaxis Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Advaxis Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 06, 2019: Advaxis presents an overview of its Lm platform and neoantigen-directed programs at the Immuno-Oncology 360 Conference

Jan 28, 2019: Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360 Conference

Jan 10, 2019: Advaxis reports fiscal year 2018 financial results and provides a business update

Sep 10, 2018: Advaxis reports fiscal 2018 third quarter financial results

Jul 10, 2018: Advaxis Provides Update on MAA Filing and ADXS-HOT Program

Jun 07, 2018: Advaxis Announces Prioritization of Product Portfolio and Reports Fiscal 2018 Second Quarter Financial Results

Jun 06, 2018: Advaxis Appoints Molly Henderson as Chief Financial Officer

May 22, 2018: COMECER AMERICA signs a new agreement for the production of an aseptic manufacturing system (isolator technology) for Advaxis

Apr 23, 2018: Advaxis Announces Executive Leadership Changes

Mar 12, 2018: Advaxis Announces Q1 Fiscal 2018 Financial Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Advaxis Inc, Performance Chart (2014-2018)

Advaxis Inc, Ratio Charts

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Advaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Advaxis Inc, Key Facts

Advaxis Inc, Key Employees

Advaxis Inc, Key Employee Biographies

Advaxis Inc, Major Products and Services

Advaxis Inc, History

Advaxis Inc, Key Competitors

Advaxis Inc, Ratios based on current share price

Advaxis Inc, Annual Ratios

Advaxis Inc, Annual Ratios (Cont...1)

Advaxis Inc, Interim Ratios

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Advaxis Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Advaxis Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Oncolytics Biotech Inc

Neon Therapeutics Inc

MedImmune LLC

ISA Pharmaceuticals BV

Inovio Pharmaceuticals Inc

Celldex Therapeutics Inc

Cascadian Therapeutics Inc

Agenus Inc

Advantagene Inc

Aduro BioTech Inc